Atalan develops a clinician wellness risk management software to help predict and address clinician burnout and turnover.
Atalan has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Atalan's investors include XLerateHealth, Excelerate Health Ventures, OCA Ventures.
Atalan is headquartered in Boston, United States.
Atalan develops a clinician wellness risk management software to help predict and address clinician burnout and turnover.
Atalan is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atalan — Funding & Investors." VCBacked, October 5, 2023, https://www.vcbacked.co/company/atalan. Accessed July 30, 2026.
VCBacked. (2023). Atalan — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/atalan
{{cite web |title=Atalan — Funding & Investors |url=https://www.vcbacked.co/company/atalan |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated